tiprankstipranks
Trending News
More News >

New Portfolio Jan 2023 - New Portfolio

Assen

New Portfolio Jan 2023
Individual Investor
Ranked #520,473 out of 818,742 TipRanks' Investors
Success Rate
39%
44 out of 113
profitable transactions
Average Return
-0.65%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 0.80%
6-Month Return▲ 0.13%
12-Month Return▲ 0.47%
YTD Return▲ 2.45%
Total Return▲ 5.11%

Best Trade

Opened at
Closed at-
Gain▲ 265.41%

Bio

LT focused portfolio with primary investment in EU based companies

Performance

27.91%0-27.91%
▼ 12.86%
▼ 1.27%
▲ 1.01%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 9.94%
Mar 2025
▲ 1.84%
▼ 0.87%
▼ 3.30%
Apr 2025
▲ 12.20%
▲ 6.28%
▲ 2.80%
May 2025
▲ 6.24%
▲ 5.14%
▼ 1.52%
Jun 2025
▲ 27.91%
▲ 2.30%
▲ 2.85%
Jul 2025
▲ 4.87%
▲ 2.05%
▲ 3.98%
Aug 2025
▲ 8.21%
▲ 2.19%
▲ 0.33%
Sep 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 12.86%▼ 1.27%▲ 1.01%
▼ 1.80%▼ 5.57%▼ 9.94%
▲ 1.84%▼ 0.87%▼ 3.30%
▲ 12.20%▲ 6.28%▲ 2.80%
▲ 6.24%▲ 5.14%▼ 1.52%
▲ 27.91%▲ 2.30%▲ 2.85%
▲ 4.87%▲ 2.05%▲ 3.98%
▲ 8.21%▲ 2.19%▲ 0.33%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Sanofi
0%
▼ 8.25%
4
Sell
Aug 17, 2025
Kering SA
0%
▼ 27.90%
6
Sell
Aug 17, 2025
Novo Nordisk
21.93%
▼ 31.33%
8
Buy
Aug 17, 2025
The Estée Lauder Companies
0%
▼ 20.04%
7
Sell
Aug 17, 2025
Tesla
9.84%
▲ 72.76%
3
Buy
Aug 17, 2025
Nvidia
7.87%
▲ 103.34%
5
Buy
Aug 17, 2025
EssilorLuxottica SA
5.93%
▲ 20.75%
3
Buy
Aug 17, 2025
LVMH Moet Hennessy Louis Vuitton
11.5%
▼ 13.27%
4
Buy
Aug 17, 2025
Barry Callebaut AG
0%
▼ 25.56%
2
Sell
Aug 17, 2025
Eli Lilly & Co
5.83%
▲ 6.84%
1
Open
Aug 17, 2025
Remy Cointreau
1.25%
▼ 51.73%
7
Buy
May 14, 2025
Brown Forman A
0.65%
▼ 37.96%
4
Buy
May 14, 2025
L'Oreal
3.45%
▼ 6.50%
2
Buy
May 14, 2025
TotalEnergies SE
4.73%
▼ 9.12%
2
Buy
May 14, 2025
Air Liquide
▲ 13.40%
4
Close
Sep 27, 2024
Ferrari
0%
▲ 2.73%
2
Sell
Sep 27, 2024
AXA SA
0%
▲ 24.15%
2
Sell
Sep 27, 2024
Alibaba
0%
▲ 94.91%
2
Sell
Sep 27, 2024
Compagnie Financiere Richemont SA
▼ 5.60%
2
Close
Sep 27, 2024
Bristol-Myers Squibb
0%
▲ 12.43%
2
Sell
Sep 27, 2024